Short chains of amino acids promise big breakthroughs in the gym. We asked the experts whether peptide stacking lives up to ...

Charcot-Marie-Tooth disease is an inherited disorder that leads to a gradual loss of motor neurons and, eventually, paralysis. The condition is caused by genetic mutations that disrupts cells' energy ...

The previous ten years have been a golden age for anti-aging studies, with breakthroughs occurring at a dizzying rate. Shinya Yamanaka, a scientist from Kyoto University in Japan, was recently awarded ...

Yale researchers revealed how vitamin B5 fuels mitochondria, offering new insight into brain and metabolic disorders. The human body produces a molecule from vitamin B5 that plays a crucial role in ...

Malate dehydrogenase isoenzymes catalyzing the oxidation of malate to oxaloacetate are highly active enzymes in mitochondria, in peroxisomes, in chloroplasts, and in the cytosol. Determination of the ...

MENLO PARK, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and ...

The new treatment leverages peptide-brush polymers, which act as a shield to prevent proteins from binding to one another. Polymer backbone is shown in yellow. Active peptides are in blue and green.

Scientists at Northwestern, and Case Western Reserve universities have developed the first polymer-based therapeutic for the genetic disorder Huntington’s disease, an incurable neurodegenerative ...

Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington's disease, an incurable, debilitating illness that causes nerve cells ...